541096 Stock Overview
Engages in the research, development, manufacturing, marketing, sourcing, and distribution of pharmaceutical products in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Bharat Parenterals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,679.65 |
| 52 Week High | ₹1,854.00 |
| 52 Week Low | ₹553.70 |
| Beta | 0.98 |
| 11 Month Change | 23.92% |
| 3 Month Change | 1.22% |
| 1 Year Change | 183.72% |
| 33 Year Change | 355.19% |
| 5 Year Change | 949.78% |
| Change since IPO | 952.41% |
Recent News & Updates
Recent updates
Shareholder Returns
| 541096 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 12.7% | 0.8% | 2.9% |
| 1Y | 183.7% | 42.1% | 28.9% |
Return vs Industry: 541096 exceeded the Indian Pharmaceuticals industry which returned 43.3% over the past year.
Return vs Market: 541096 exceeded the Indian Market which returned 28.6% over the past year.
Price Volatility
| 541096 volatility | |
|---|---|
| 541096 Average Weekly Movement | 5.8% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 541096 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 541096's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 363 | Bharatkumar Desai | bplindia.in |
Bharat Parenterals Limited engages in the research, development, manufacturing, marketing, sourcing, and distribution of pharmaceutical products in India. The company provides products in the areas of antibiotics, anti-retroviral, antiprotozoal/anthelmintic, respiratory, antiallergic/anti-histaminic/anticold, cleansing agents/skin infections, cardiovascular systems, anti-diabetic, anti-tuberculosis, anti-fungal, antimalarial, gastrointestinal tract/alimentary systems, anti-inflammatory/anti-pyretic/analgesics, supplements, central nervous system, anaesthetics, anti-viral, steroids and hormones, uterine stimulant, anticancer, and others. It also provides general products, ß-lactum /cephalosporin products, and formulations.
Bharat Parenterals Limited Fundamentals Summary
| 541096 fundamental statistics | |
|---|---|
| Market cap | ₹10.96b |
| Earnings (TTM) | -₹27.53m |
| Revenue (TTM) | ₹2.94b |
3.7x
P/S Ratio-398.1x
P/E RatioIs 541096 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 541096 income statement (TTM) | |
|---|---|
| Revenue | ₹2.94b |
| Cost of Revenue | ₹1.79b |
| Gross Profit | ₹1.15b |
| Other Expenses | ₹1.18b |
| Earnings | -₹27.53m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -4.22 |
| Gross Margin | 39.07% |
| Net Profit Margin | -0.94% |
| Debt/Equity Ratio | 42.7% |
How did 541096 perform over the long term?
See historical performance and comparison